Results 21 to 30 of about 43,044 (314)
Systemic Cytokines in Retinopathy of Prematurity
Journal of Personalized Medicine, 2023 Retinopathy of prematurity (ROP), a vasoproliferative vitreoretinal disorder, is the leading cause of childhood blindness worldwide. Although angiogenic pathways have been the main focus, cytokine-mediated inflammation is also involved in ROP etiology ...
Po-Yi Wu +13 more
semanticscholar +1 more source
Pathophysiology of Retinopathy of Prematurity.
Annual Review of Vision Science, 2023 Retinopathy of prematurity (ROP) is a complex disease involving development of the neural retina, ocular circulations, and other organ systems of the premature infant.
M. E. Hartnett
semanticscholar +1 more source
Journal of the American Medical Association (JAMA), 2022 Importance Laser photocoagulation, which is the standard treatment for retinopathy of prematurity (ROP), can have adverse events. Studies of anti-vascular endothelial growth factor injections have suggested efficacy in the treatment of ROP, but few ...
A. Stahl +15 more
semanticscholar +1 more source
Retinopathy of Prematurity [PDF]
North Carolina Medical Journal, 2017 Retinopathy of prematurity (ROP) is a vasoproliferative retinal disorder unique to premature infants. As premature births increase in many areas of the world, ROP has become a leading cause of childhood blindness. A better understanding of the pathogenesis of ROP, adherence to strict screening guidelines, and evolution of treatment options have reduced
Mukta Sharma, Anil Chauhan
openaire +4 more sources
Risk factors associated with Retinopathy of Prematurity development and progression
Scientific Reports, 2022 Several studies propose that Retinopathy of Prematurity (ROP) is a multifactorial disorder implicating many prenatal and postnatal factors. The objective of our study was to determine the incidence and the risk factors that influenced ROP development and
N. de las Rivas Ramírez +4 more
semanticscholar +1 more source
Pathophysiology of retinopathy of prematurity
Saudi Journal of Ophthalmology, 2022 Retinopathy of prematurity (ROP) is a vasoproliferative disease occurring in premature infants that affects the blood vessels of the developing retina.
Y. N. Strube, K. Wright
semanticscholar +1 more source
Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity
JAMA pediatrics, 2021 Key Points Question Does enteral fatty acid supplementation with arachidonic acid (AA) and docosahexaenoic acid (DHA) from birth to 40 weeks’ postmenstrual age reduce severe retinopathy of prematurity (ROP) in extremely preterm infants?
A. Hellström +19 more
semanticscholar +1 more source
Journal of Nepal Medical Association, 2023 Introduction: World Health Organization has identified retinopathy of prematurity as an important cause of preventable childhood blindness. The presentation of retinopathy of prematurity is varied and differs in the developed and developing worlds.
Pradeep Bastola +4 more
doaj +1 more source
Retinopathy of prematurity: a review of epidemiology and current treatment strategies
Clinical and experimental pediatrics, 2021 Retinopathy of prematurity (ROP) is among the most common causes of childhood blindness. Three phases of ROP epidemics have been observed worldwide since ROP was first described in the 1940s.
E. Hong, Y. Shin, Hee-Joon Cho
semanticscholar +1 more source
JAMA Network Open, 2021 This cohort study evaluates the association of long-chain polyunsaturated fatty acid serum levels with the development of retinopathy of prematurity in extremely preterm infants.
A. Hellström +9 more
semanticscholar +1 more source